These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 29676250)

  • 21. Plasmodium falciparum kelch 13: a potential molecular marker for tackling artemisinin-resistant malaria parasites.
    Mita T; Tachibana S; Hashimoto M; Hirai M
    Expert Rev Anti Infect Ther; 2016; 14(1):125-35. PubMed ID: 26535806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artemisinin resistance in Plasmodium falciparum: what is it really?
    Ferreira PE; Culleton R; Gil JP; Meshnick SR
    Trends Parasitol; 2013 Jul; 29(7):318-20. PubMed ID: 23768531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemisinin-Resistant Plasmodium falciparum Malaria.
    Fairhurst RM; Dondorp AM
    Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Origin and Spread of Evolving Artemisinin-Resistant
    Hassett MR; Roepe PD
    Am J Trop Med Hyg; 2019 Dec; 101(6):1204-1211. PubMed ID: 31642425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance.
    Chhibber-Goel J; Sharma A
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():49-58. PubMed ID: 31606696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study.
    Hamilton WL; Amato R; van der Pluijm RW; Jacob CG; Quang HH; Thuy-Nhien NT; Hien TT; Hongvanthong B; Chindavongsa K; Mayxay M; Huy R; Leang R; Huch C; Dysoley L; Amaratunga C; Suon S; Fairhurst RM; Tripura R; Peto TJ; Sovann Y; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Chau NH; Imwong M; Dhorda M; Vongpromek R; Chan XHS; Maude RJ; Pearson RD; Nguyen T; Rockett K; Drury E; Gonçalves S; White NJ; Day NP; Kwiatkowski DP; Dondorp AM; Miotto O
    Lancet Infect Dis; 2019 Sep; 19(9):943-951. PubMed ID: 31345709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
    Blasco B; Leroy D; Fidock DA
    Nat Med; 2017 Aug; 23(8):917-928. PubMed ID: 28777791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.
    Imwong M; Suwannasin K; Kunasol C; Sutawong K; Mayxay M; Rekol H; Smithuis FM; Hlaing TM; Tun KM; van der Pluijm RW; Tripura R; Miotto O; Menard D; Dhorda M; Day NPJ; White NJ; Dondorp AM
    Lancet Infect Dis; 2017 May; 17(5):491-497. PubMed ID: 28161569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for artemisinin-resistant malaria.
    Koehne E; Adegnika AA; Held J; Kreidenweiss A
    Expert Opin Pharmacother; 2021 Dec; 22(18):2483-2493. PubMed ID: 34311639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.
    Amaratunga C; Sreng S; Suon S; Phelps ES; Stepniewska K; Lim P; Zhou C; Mao S; Anderson JM; Lindegardh N; Jiang H; Song J; Su XZ; White NJ; Dondorp AM; Anderson TJ; Fay MP; Mu J; Duong S; Fairhurst RM
    Lancet Infect Dis; 2012 Nov; 12(11):851-8. PubMed ID: 22940027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The challenge of artemisinin resistance can only be met by eliminating Plasmodium falciparum malaria across the Greater Mekong subregion.
    Smith Gueye C; Newby G; Hwang J; Phillips AA; Whittaker M; MacArthur JR; Gosling RD; Feachem RG
    Malar J; 2014 Jul; 13():286. PubMed ID: 25064614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.
    Rosenthal PJ; Asua V; Conrad MD
    Nat Rev Microbiol; 2024 Jun; 22(6):373-384. PubMed ID: 38321292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
    Amato R; Lim P; Miotto O; Amaratunga C; Dek D; Pearson RD; Almagro-Garcia J; Neal AT; Sreng S; Suon S; Drury E; Jyothi D; Stalker J; Kwiatkowski DP; Fairhurst RM
    Lancet Infect Dis; 2017 Feb; 17(2):164-173. PubMed ID: 27818095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global distribution of polymorphisms associated with delayed Plasmodium falciparum parasite clearance following artemisinin treatment: genotyping of archive blood samples.
    Murai K; Culleton R; Hisaoka T; Endo H; Mita T
    Parasitol Int; 2015 Jun; 64(3):267-73. PubMed ID: 25449286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
    van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
    Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia.
    Dwivedi A; Reynes C; Kuehn A; Roche DB; Khim N; Hebrard M; Milanesi S; Rivals E; Frutos R; Menard D; Mamoun CB; Colinge J; Cornillot E
    Malar J; 2017 Dec; 16(1):493. PubMed ID: 29258508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.